This article is more than 5 years old. Information may no longer be current.
Barbara Ann Karmanos Cancer Hospital appoints president
Click Here to Manage Email Alerts
Justin F. Klamerus, MD, MMM, has been appointed president of Barbara Ann Karmanos Cancer Hospital.
The hospital is the clinical operation of Karmanos Cancer Institute in Detroit.
Klamerus — who served as interim president since April — will oversee all clinical operations at Karmanos’ treatment locations. He also will continue to serve as associate professor of oncology at Wayne State University School of Medicine.
Klamerus joined Karmanos in 2014. He previously oversaw operations for Karmanos Cancer Network, which includes 14 cancer centers in Michigan. He also served as executive vice president and chief quality officer, as well as associate center director for community oncology.
“I’m confident Dr. Klamerus will continue to do an outstanding job leading our clinical operations,” Gerold Bepler, MD, PhD, president and CEO of Karmanos Cancer Institute, said in a press release. “His experience prior to coming to Karmanos, as well as his track record since arriving here in early 2014, has earned the respect of staff. ... His insight as a physician and his ability to bring people together to work toward our mission of providing our patients with outstanding cancer care will continue to be a priority as we navigate the ever-changing health care environment.”
Klamerus previously served as president and medical director of McLaren Cancer Institute, as well as cancer program director at McLaren Northern Michigan.
“I have had the privilege of working with the exceptional team at Karmanos for the past 3 years and have seen firsthand their unprecedented level of compassion, commitment and expertise when serving our patients,” Klamerus said in the press release. “I’m honored to serve as the next president of Karmanos Cancer Hospital and I know, together with Dr. Bepler and our team, we will continue to provide high-quality, state-of-the-science cancer care with compassion, dignity and determination that will lead to the next standard of cancer care.”